Studies on formulation and in vitro evaluation of floating matrix tablets of domperidone

Indian Journal of Pharmaceutical Sciences

Volumn 71, Issue 1, 2009, Pages 19-23

  Prajapati, S T ^a   Patel, L D ^b   Patel, D M ^a  

^a Shri Sarvajanik Pharmacy College   (India)

^b DHARMSINH DESAI UNIVERSITY   (India)

Author keywords

Domperidone; Floating lag time; Floating matrix tablet; Total floating time

Indexed keywords

ALGINIC ACID; CARBOMER; DOMPERIDONE; HYDROXYPROPYLMETHYLCELLULOSE;

ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; MATRIX TABLET; STOMACH ABSORPTION; TABLET COMPRESSION; TABLET FRIABILITY; TABLET HARDNESS;

EID: 67650215105     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.51944     Document Type: Article

References (15)

1. Hoffman A. Pharmacodynamic aspects of sustained release preparations. Adv Drug Deliv Rev 1998;33:185-99.
2. Hoffman A, Stepensky D. Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy. Crit Rev Ther Drug Carrier Syst 1999;16:571-639.
3. Hwang SJ, Park H, Park K. Gastric retentive drug delivery systems. Crit Rev Ther Drug Carrier Syst 1998;15:243-84.
4. Deshpande AA, Shah NH, Rhodes CT, Malick W. Controlled release drug delivery systems for prolonged gastric residence: an overview. Drug Develop Ind Pharm 1996;22:531-9.
5. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release 2000;63:235-59.
6. Moes AJ. Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst 1993;10:143-95.
7. Rubinstein A, Friend DR. In: Domb A.J. editors, Polymeric Site-Specifc Pharmacotherapy, Chichester Wiley 1994, p. 267-313.
8. Mamjek RC, Moyer ES. Drug Dispensing Device and Method. 1980, U.S. Patent. 4,207,890.
9. Reynolds JEF. In: Martindale; The Extra Pharmacopoeia, 31st ed., London: Pharmaceutical Press; 1996. p.1217-8.
10. Albright LM. Use of Domperidone as a Prokinetic and Antiemetic, Health and Wellness. Int J Pharm Compounding 2005;9:120-5.
11. Mehta B, Doshi P, Madhukant M, Dattat M. Floating osmotic device for controlled release drug delivery. 3 March 2003, US Pat. 992897.
12. Naonori K., Yatabe H., Iseki K. A new type of pH independent controlled release tablet, Int J Pharm 1991;68:255-64.
13. Thomma K, Zimmer T. Retardation of weakly basic drug with diffusion tablet. Int J Pharm 1990;58:197-202.
14. Sheth PR and Tossounian JL. Sustained release tablet formulations. 2 February 1979, U.S. Pat. 4140755.
15. Rosa M, Zia H, Rhodes T. Dosing and testing in-vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm 1994;105:65-70.